{"id":"https://openalex.org/W2188478576","doi":null,"title":"Hypolipidemic and Anti-atherogenic Effect of Sulphated Polysaccharides","display_name":"Hypolipidemic and Anti-atherogenic Effect of Sulphated Polysaccharides","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2188478576","mag":"2188478576"},"language":"en","primary_location":{"id":"mag:2188478576","doi":null,"is_oa":false,"landing_page_url":"http://globalresearchonline.net/journalcontents/v31-1/01.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049181029","display_name":"Ibrahim H. Borai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ibrahim H. Borai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013432175","display_name":"Magda K. Ezz","orcid":"https://orcid.org/0000-0001-6805-1013","observed_orcids":["https://orcid.org/0000-0001-6805-1013"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Magda K. Ezz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083043820","display_name":"Maha Z. Rizk","orcid":"https://orcid.org/0000-0002-1289-3112","observed_orcids":["https://orcid.org/0000-0002-1289-3112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maha Z. Rizk","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1289-3112","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111940088","display_name":"Mahmoud El-Sherbiny","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahmoud El-Sherbiny","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039851010","display_name":"Azza Abdelmageed Matloub","orcid":"https://orcid.org/0000-0003-3358-5546","observed_orcids":["https://orcid.org/0000-0003-3358-5546"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Azza A. Matloub","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3358-5546","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020144453","display_name":"Hanan Farouk Aly","orcid":"https://orcid.org/0000-0003-3642-1571","observed_orcids":["https://orcid.org/0000-0003-3642-1571"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hanan F. Aly","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3642-1571","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016080086","display_name":"Abd El Razik H Farrag","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abd El Razik H Farrag","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5023788158","display_name":"Ghadha Ibrahim Fouad","orcid":"https://orcid.org/0000-0003-3665-3153","observed_orcids":["https://orcid.org/0000-0003-3665-3153"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ghadha Ibrahim Fouad","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3665-3153","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.07657303,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11390","display_name":"Seaweed-derived Bioactive Compounds","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1104","display_name":"Aquatic Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11390","display_name":"Seaweed-derived Bioactive Compounds","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1104","display_name":"Aquatic Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13828","display_name":"Natural Products and Biological Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sulfated-polysaccharides","display_name":"sulfated polysaccharides","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ulva-fasciata","display_name":"Ulva fasciata","score":1.0},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9549999833106995},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.9700000286102295},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.7549999952316284},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.8970000147819519},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.765999972820282},{"id":"https://openalex.org/keywords/cell-adhesion-molecules","display_name":"adhesion molecules","score":0.8259999752044678},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.6919999718666077},{"id":"https://openalex.org/keywords/fluvastatin","display_name":"fluvastatin","score":0.7639999985694885},{"id":"https://openalex.org/keywords/statin-alternatives","display_name":"statin alternatives","score":0.6050000190734863},{"id":"https://openalex.org/keywords/seaweed-extract","display_name":"seaweed extract","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C100817775","wikidata":"https://www.wikidata.org/wiki/Q134219","display_name":"Polysaccharide","level":2,"score":0.6565406322479248},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.6499724984169006},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5484541058540344},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5121550559997559},{"id":"https://openalex.org/C2778417548","wikidata":"https://www.wikidata.org/wiki/Q417942","display_name":"Fluvastatin","level":3,"score":0.47414630651474},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4562283158302307},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.43649420142173767},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37020158767700195},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32905054092407227},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2854814827442169},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188478576","doi":null,"is_oa":false,"landing_page_url":"http://globalresearchonline.net/journalcontents/v31-1/01.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W28630372","https://openalex.org/W1498523402","https://openalex.org/W1578728271","https://openalex.org/W1946263363","https://openalex.org/W1976629616","https://openalex.org/W1979151464","https://openalex.org/W1985986220","https://openalex.org/W1989366288","https://openalex.org/W1995534939","https://openalex.org/W1996186320","https://openalex.org/W2006921001","https://openalex.org/W2030546388","https://openalex.org/W2033937087","https://openalex.org/W2041247294","https://openalex.org/W2044089686","https://openalex.org/W2044237381","https://openalex.org/W2050335944","https://openalex.org/W2053393895","https://openalex.org/W2062124231","https://openalex.org/W2077790464","https://openalex.org/W2083719015","https://openalex.org/W2090311026","https://openalex.org/W2109275204","https://openalex.org/W2115762872","https://openalex.org/W2116219173","https://openalex.org/W2116404316","https://openalex.org/W2127258766","https://openalex.org/W2138574610","https://openalex.org/W2140760627","https://openalex.org/W2147976151","https://openalex.org/W2154774609","https://openalex.org/W2411651338","https://openalex.org/W4253817277"],"related_works":["https://openalex.org/W2417120671","https://openalex.org/W2067116154","https://openalex.org/W2571915805","https://openalex.org/W2033937087","https://openalex.org/W4391998672","https://openalex.org/W4400974998","https://openalex.org/W2425489006","https://openalex.org/W2586245113","https://openalex.org/W4401410825","https://openalex.org/W2510447305"],"abstract_inverted_index":{"Hypercholesterolemia":[0],"(HC)":[1],"is":[2,72,91],"frequently":[3],"associated":[4,65,236,264],"with":[5,66,158,196,237],"oxidative":[6,150],"stress,":[7],"and":[8,13,18,31,59,63,98,143,148,155,169,190,205,249,275,288,295],"release":[9],"of":[10,20,43,76,87,112,116,126,164,209,229,239,270],"inflammatory":[11,139,240,273],"cytokines":[12],"results":[14,254],"in":[15,23,34,122,212,243,261,279,282],"the":[16,24,35,41,85,109,136,159,192,197,207,213,217,227],"formation":[17,278],"accumulation":[19],"plaque":[21,277],"deposits":[22],"arteries,":[25],"where":[26],"it":[27],"produces":[28],"numerous":[29],"functional":[30],"structural":[32],"alterations":[33],"vascular":[36],"wall":[37],"that":[38,226,242,256,281],"lead":[39,245,284],"to":[40,54,107,134,172,246,285],"development":[42],"atherosclerosis":[44],"or":[45],"coronary":[46,67],"heart":[47,68,265,296],"disease":[48],"(CHD).":[49],"Statins":[50],"have":[51],"been":[52],"shown":[53],"effectively":[55,201],"lower":[56],"LDL-C":[57],"levels":[58],"reduce":[60],"both":[61],"mortality":[62],"morbidity":[64],"disease,":[69],"although":[70],"there":[71],"a":[73,130],"significant":[74],"percentage":[75],"individuals":[77],"for":[78,95,174],"whom":[79],"statin":[80],"therapy":[81],"will":[82],"not":[83,179],"prevent":[84],"occurrence":[86],"adverse":[88],"events.":[89],"There":[90],"an":[92],"obvious":[93],"need":[94],"more":[96,215],"efficacious":[97],"alternative":[99],"treatment":[100,157],"options.":[101],"The":[102],"present":[103],"study":[104],"was":[105,200],"undertaken":[106],"evaluate":[108],"atheropreventive":[110],"activity":[111],"sulphated":[113],"polysaccharides":[114],"(SPs)":[115],"Ulva":[117,165],"fasciata":[118,166,232],"against":[119],"induced":[120],"hypercholesterolemia":[121,248,287],"rats.":[123],"Different":[124],"groups":[125],"rats":[127],"were":[128],"administered":[129],"high":[131],"cholesterol":[132],"diet":[133],"assess":[135],"lipid":[137,187,271],"profile,":[138,272],"markers":[140,241],"(IL-10,":[141],"MPO)":[142],"cell":[144],"adhesion":[145],"molecules":[146],"(ICAM-1":[147],"VCAM-1),":[149],"stress":[151],"marker":[152],"(NO)":[153],"before":[154],"after":[156],"algal":[160,198],"polysaccharides.":[161],"Oral":[162],"administration":[163],"crude":[167],"cold":[168],"hot":[170],"extracts":[171],"HC-rats":[173],"four":[175],"consecutive":[176],"weeks":[177],"did":[178],"exert":[180],"any":[181],"side":[182],"effects,":[183],"whereas":[184],"reduced":[185],"serum":[186],"profile":[188],"level":[189],"improved":[191,202],"endothelial":[193],"dysfunction.":[194],"Treatment":[195],"SPs":[199,257],"these":[203],"disorders":[204],"diminished":[206],"presence":[208],"atherogenic":[210,276],"plaques":[211],"aorta":[214],"than":[216],"reference":[218],"drug":[219],"fluvastatin.":[220],"It":[221],"could":[222],"thus":[223],"be":[224,235,259],"concluded":[225],"consumption":[228],"UFP":[230],"(Ulva":[231],"polysaccharides),":[233],"may":[234,258],"attenuation":[238,269],"turn":[244,283],"control":[247,286],"its":[250,289],"related":[251,290],"disorders.":[252],"These":[253],"suggest":[255],"beneficial":[260],"ameliorating":[262],"hypercholesterolemia-":[263],"injury":[266],"probably":[267],"by":[268],"markers,":[274],"heart,":[280],"disorders;":[291],"such":[292],"as":[293],"obesity,":[294],"disease.":[297]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}